4
Changes in Ownership
Cytosorbents Corp Filed Acc 0001144204-18-001799
Chief Financial Officer sold 32,400 shares at an average $7.30 ($236,400)
- Chief Financial Officer acquired 32,400 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-01-08 | Option exercise | +20,000 | $2.90 | $58,000 | 248,638 | D: show line 1 in the form |
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-01-08 | Option exercise | +12,400 | $4.69 | $58,156 | 261,038 | D: show line 2 in the form |
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-01-08 | Sale | −10,000 | $7.15 | $71,500 | 251,038 | D: show line 3 in the form |
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-01-08 | Sale | −12,400 | $7.25 | $89,900 | 238,638 | D: show line 4 in the form |
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-01-08 | Sale | −10,000 | $7.50 | $75,000 | 228,638 | D: show line 5 in the form |
| Open-market sales · 32,400 sh · avg $7.30 · $236,400 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-01-08 | Option exercise · Stock Option (Right to Buy) | −20,000 | 20,000 | D: show line 6 in the form | ||
| BLOCH KATHLEEN P. Chief Financial Officer | 2018-01-08 | Option exercise · Stock Option (Right to Buy) | −12,400 | 49,600 | D: show line 7 in the form |
Loading xslF345X03/tv483029_4.xml…